Raymond James & Associates Ishares Tr Genomics Immunology Transaction History

Raymond James & Associates

  • $150 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
SELL
$26.31 - $34.57 $12,786 - $16,801
-486 Reduced 5.27%
8,729 $230,000
Q2 2022

Aug 12, 2022
SELL
$25.09 - $35.91 $115,288 - $165,006
-4,595 Reduced 33.27%
9,215 $266,000
Q1 2022

May 11, 2022
BUY
$31.36 - $43.88 $38,416 - $53,753
1,225 Added 9.73%
13,810 $476,000
Q4 2021

Feb 08, 2022
BUY
$43.23 - $51.35 $544,049 - $646,239
12,585 New
12,585 $551,000

Others Institutions Holding IDNA

# of Institutions
66
Shares Held
1.83M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email